Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention.
Medicine, Emory University, Atlanta.
J Infect Dis. 2024 May 8;229(Supplement_3):S350-S356. doi: 10.1093/infdis/jiad199.
An estimated 2.4 million people in the United States are living with hepatitis C virus (HCV) infection. In 2020, the Centers for Disease Control and Prevention updated hepatitis C screening recommendations to test adults aged ≥18 years at least once in a lifetime and pregnant persons during each pregnancy. For those with ongoing exposure to HCV, periodic testing is recommended. The recommended testing sequence is to obtain an HCV antibody test and, when positive, perform an HCV RNA test. Examination of HCV care cascades has found that incomplete HCV testing occurs when a separate visit is required to obtain the HCV RNA test. Hepatitis C core antigen testing has been shown to be a useful tool for diagnosing current HCV infection in some settings. Hepatitis C testing that is completed, accurate, and efficient is necessary to achieve hepatitis C elimination goals.
据估计,美国有 240 万人感染了丙型肝炎病毒 (HCV)。2020 年,疾病控制与预防中心更新了丙型肝炎筛查建议,要求年龄≥18 岁的成年人一生中至少进行一次筛查,孕妇在每次怀孕时都要进行筛查。对于那些持续接触 HCV 的人,建议定期进行检测。推荐的检测顺序是先进行 HCV 抗体检测,如果阳性,则进行 HCV RNA 检测。对 HCV 护理流程的研究发现,当需要单独就诊进行 HCV RNA 检测时,会出现 HCV 检测不完整的情况。丙型肝炎核心抗原检测已被证明在某些情况下是诊断当前 HCV 感染的有用工具。为了实现丙型肝炎消除目标,有必要进行完整、准确和高效的丙型肝炎检测。